In an interview to CNBC-TV 18 Aashish Tater, Head of Research, Fortunewizard.com is bullish on Pharma sector. He discusses Glenmark and Cipla which are a buy for atleast a period of 12-18 months.
first published: Nov 15, 2012 12:25 pm
A collection of the most-viewed Moneycontrol videos.

How SIP Top-Ups Can Boost Your Wealth | Smart Investing Made Simple

Nifty Reclaims 26,000; Nifty Bank Hits New Life High| Groww Joins RS 1 Lk Cr Club| Closing Bell Live

Nifty Headed For All-Time Highs After Friday’s Late Recovery?| Opening Bell Live

This Tenant Moved from a 100sqft Slum to a Premium Residence | The Tenant
You are already a Moneycontrol Pro user.

